{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:06:15Z","timestamp":1793300775460,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The prolonged treatment recommended for nocardiosis does not rely on strong evidence. Consequently, some clinicians opt shorter therapy in certain circumstances. We assessed the effectiveness of shorter therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A multi-center retrospective cohort study comprising individuals diagnosed with nocardiosis between 2007 and 2022. We classified all patients who survived 90 days into three groups according to treatment duration: short (\u2264\u200990 days), intermediate (91\u2013180 days), and prolonged (&gt;\u2009180 days). We compared baseline characteristics (comorbidities, immune status) and nocardiosis manifestations across the unadjusted treatment groups, one-year all-cause mortality, disease relapse, and antibiotic-related adverse events to identify patients who may safely receive the short course.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We detected 176 patients with nocardiosis, their median age was 65 years; 74 (42%) were women. Forty-three (24%) patients died within 90 days. Of the remaining 133, 37 (28%) patients received short therapy, 40 (30%) intermediate, and 56 (42%) prolonged treatment duration. Longer courses were more likely to be administered to patients with immunosuppression, disseminated nocardiosis, and <jats:italic>N. farcinica<\/jats:italic> infection. Within a year, 20 (15%) individuals died and 2 (2%) relapsed. Treatment duration was not associated with either mortality (<jats:italic>p<\/jats:italic>\u2009=\u20090.945) or relapse (<jats:italic>p<\/jats:italic>\u2009=\u20090.509). Nocardiosis was the cause of death in only one patient, receiving a prolonged course. Of 73 patients with solitary pulmonary nocardiosis, 20 (27%) received short duration. None relapsed and 2 (10%) died, both immunocompromised. The rate of AE was similar across the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>With clinically guided case-by-case patient selection nocardiosis can be safely treated for durations significantly shorter than traditionally recommended.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s15010-024-02445-0","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:38:10Z","timestamp":1732631890000},"page":"1115-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study"],"prefix":"10.1007","volume":"53","author":[{"given":"Nofar Hezkelo","family":"Attias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Schlaeffer-Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Zahavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noga","family":"Hasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaara Ben","family":"Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Darawsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idan","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Landes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Litchevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Ben-Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Nesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Bishara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ili","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"issue":"9","key":"2445_CR1","doi-asserted-by":"publisher","first-page":"e13509","DOI":"10.1111\/ctr.13509","volume":"33","author":"A Restrepo","year":"2019","unstructured":"Restrepo A, Clark NM, Infectious Diseases Community of Practice of the American Society of Transplantation. Nocardia infections in solid organ transplantation: guidelines from the infectious diseases Community of Practice of the American Society of Transplantation. Clin Transpl. 2019;33(9):e13509.","journal-title":"Clin Transpl"},{"issue":"4","key":"2445_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cmi.2020.12.019","volume":"27","author":"I Margalit","year":"2021","unstructured":"Margalit I, Lebeaux D, Tishler O, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021;27(4):550\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2445_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00000441-197911000-00001","volume":"278","author":"PJ Geiseler","year":"1979","unstructured":"Geiseler PJ, Andersen BR. Results of therapy in systemic nocardiosis. Am J Med Sci. 1979;278(3):188\u201394.","journal-title":"Am J Med Sci"},{"issue":"2","key":"2445_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/clinids\/4.2.315","volume":"4","author":"RJ Wallace","year":"1982","unstructured":"Wallace RJ, Septimus EJ, Williams TW, et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982;4(2):315\u201325.","journal-title":"Rev Infect Dis"},{"issue":"4","key":"2445_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1399-3062.2010.00588.x","volume":"13","author":"MF Tripodi","year":"2011","unstructured":"Tripodi MF, Durante-Mangoni E, Fortunato R, et al. In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis. Transpl Infect Dis. 2011;13(4):335\u201343.","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"2445_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/cid\/cix124","volume":"64","author":"D Lebeaux","year":"2017","unstructured":"Lebeaux D, Freund R, van Delden C, et al. Outcome and treatment of Nocardiosis after solid organ transplantation: New insights from a European study. Clin Infect Dis. 2017;64(10):1396\u2013405. https:\/\/doi.org\/10.1093\/cid\/cix124.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2445_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciab866","volume":"75","author":"D Averbuch","year":"2022","unstructured":"Averbuch D, De Greef J, Dur\u00e9ault A, et al. Nocardia Infections in hematopoietic cell transplant recipients: a Multicenter International Retrospective Study of the infectious diseases Working Party of the European Society for Blood and marrow transplantation. Clin Infect Dis. 2022;75(1):88\u201397.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2445_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10096-019-03796-5","volume":"39","author":"I Margalit","year":"2020","unstructured":"Margalit I, Muhsen K, Ben Ari Y, et al. Nocardia colonization in contrast to nocardiosis: a comparison of patients\u2019 clinical characteristics. Eur J Clin Microbiol Infect Dis. 2020;39(4):759\u201363.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9596","key":"2445_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"1","key":"2445_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12879-024-09519-2","volume":"24","author":"W Thipmontree","year":"2024","unstructured":"Thipmontree W, Suputtamonkol Y. Comparison of clinical outcomes of pulmonary nocardiosis between AIDS and non-AIDS patients. BMC Infect Dis. 2024;24(1):649.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"2445_CR11","doi-asserted-by":"publisher","first-page":"ofad409","DOI":"10.1093\/ofid\/ofad409","volume":"10","author":"ZA Yetmar","year":"2023","unstructured":"Yetmar ZA, Khodadadi RB, Chesdachai S, et al. Mortality after nocardiosis: risk factors and evaluation of disseminated infection. Open Forum Infect Dis. 2023;10(8):ofad409.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"2445_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jinf.2022.05.029","volume":"85","author":"S Soueges","year":"2022","unstructured":"Soueges S, Bouiller K, Botelho-Nevers E, et al. Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study. J Infect. 2022;85(2):130\u20136.","journal-title":"J Infect"},{"issue":"4","key":"2445_CR13","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s40121-021-00495-7","volume":"10","author":"I Margalit","year":"2021","unstructured":"Margalit I, Yahav A, Ben Ari Y, et al. The role of 18-Fluorodeoxyglucose Positron Emission Tomography\/Computed tomography (FDG-PET\/CT) in management of nocardiosis: a retrospective study and review of the literature. Infect Dis Ther. 2021;10(4):2227\u201346.","journal-title":"Infect Dis Ther"},{"issue":"7","key":"2445_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2967\/jnumed.118.221929","volume":"60","author":"MAH Berrevoets","year":"2019","unstructured":"Berrevoets MAH, Kouijzer IJE, Slieker K, et al. 18F-FDG PET\/CT-Guided treatment duration in patients with high-risk Staphylococcus Aureus Bacteremia: a proof of Principle. J Nucl Med. 2019;60(7):998\u20131002.","journal-title":"J Nucl Med"},{"key":"2445_CR15","doi-asserted-by":"crossref","unstructured":"Kubo K, Sakuraya M, Sugimoto H et al. Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis. Crit Care Med. Published online July 1, 2024.","DOI":"10.1097\/CCM.0000000000006366"},{"issue":"3","key":"2445_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/AAC.1.3.215","volume":"1","author":"MG Orfanakis","year":"1972","unstructured":"Orfanakis MG, Wilcox HG, Smith CB. In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients. Antimicrob Agents Chemother. 1972;1(3):215\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"2445_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijid.2018.12.010","volume":"81","author":"SR Ott","year":"2019","unstructured":"Ott SR, Meier N, Kolditz M, et al. Pulmonary nocardiosis in Western Europe-Clinical evaluation of 43 patients and population-based estimates of hospitalization rates. Int J Infect Dis. 2019;81:140\u20138.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"2445_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ijmmb.2022.08.010","volume":"40","author":"MM Ninan","year":"2022","unstructured":"Ninan MM, Venkatesan M, Balaji V, Rupali P, Michael JS. Pulmonary nocardiosis: risk factors and species distribution from a high burden centre. Indian J Med Microbiol. 2022;40(4):582\u20134.","journal-title":"Indian J Med Microbiol"},{"issue":"9","key":"2445_CR19","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/cid\/ciy1134","volume":"69","author":"N Wald-Dickler","year":"2019","unstructured":"Wald-Dickler N, Spellberg B. Short-course antibiotic therapy-replacing Constantine Units with shorter is better. Clin Infect Dis. 2019;69(9):1476\u20139.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02445-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:54:37Z","timestamp":1749016477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02445-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02445-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We did not use artificial intelligence tools during the preparation of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI in scientific writing"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}